Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend from March 31, 2024 to September 30, 2024
March 02, 2024 15:25 ET | Scilex Holding Company
PALO ALTO, Calif., March 02, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative revenue-generating company focused on acquiring, developing and commercializing...
Epsilon Ltd Logo Large.jpg
Epsilon Energy Ltd. Announces the Following Headlines
March 01, 2024 19:12 ET | Epsilon Energy Ltd.
Board declares dividend of $0.0625 per common shareCompany announces the timing of its 2023 year end earnings release and conference call HOUSTON, March 01, 2024 (GLOBE NEWSWIRE) -- Epsilon...
ADIL Logo.png
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
March 01, 2024 19:00 ET | Adial Pharmaceuticals, Inc
CHARLOTTESVILLE, Va., March 01, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...
Honest Logo.jpg
The Honest Company Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 01, 2024 18:00 ET | The Honest Company, Inc.
LOS ANGELES, March 01, 2024 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ: HNST), a personal care company dedicated to creating clean- and sustainably-designed products, today announced that it...
Zentalis logo.png
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK & SAN DIEGO, March 01, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically...
MacroGenics to Participate in Upcoming Investor Conferences
March 01, 2024 17:48 ET | MacroGenics, Inc.
ROCKVILLE, MD, March 01, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...
Millicom (Tigo) share repurchase activity
March 01, 2024 17:30 ET | Millicom International Cellular S.A.
Millicom (Tigo) share repurchase activity Luxembourg, March 1, 2024 – Pursuant to the share repurchase program announced on December 15, 2023, Millicom repurchased 52,576 of its Swedish Depository...
ICU Medical logo.jpg
ICU Medical to Present at the Raymond James 45ᵗʰ Annual Institutional Investors Conference
March 01, 2024 17:15 ET | ICU Medical, Inc.
SAN CLEMENTE, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that...
Brookfield Property Partners Completes 2023 Annual Filings
March 01, 2024 17:12 ET | Brookfield Property Partners L.P.
BROOKFIELD NEWS, March 01, 2024 (GLOBE NEWSWIRE) -- Brookfield Property Partners announced today that it has filed its 2023 annual report on Form 20-F, including its audited financial statements for...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 01, 2024 17:08 ET | Taysha Gene Therapies, Inc.
DALLAS, March 01, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for...